[1]
Aiello, A., Mancuso, M.E., Leone, S., Rossi, L., Cioni, L. and Teruzzi, C. 2022. Cost analysis of extended half-life recombinant factor IX products in the treatment of haemophilia B in Italy: an update. Global & Regional Health Technology Assessment. 9, 1 (Jan. 2022), 9–13. DOI:https://doi.org/10.33393/grhta.2022.2331.